Results 91 to 100 of about 6,597 (237)
Effectors of Inflammation in Actinic Prurigo
, 2001 peer reviewedBACKGROUND: Actinic prurigo is a specific familial photodermatosis of uncertain pathogenesis. OBJECTIVE: Our purpose was to investigate the immunohistologic presentation of actinic prurigo to explore the involved pathomechanisms.
Arrese, J. E. +13 more
core +1 more source
Prurigo pigmentosa following laparoscopic gastric sleeve [PDF]
, 2019 Prurigo pigmentosa is an uncommon inflammatory skin disease predominately affecting young women. Clinically the disease presents with erythematous and urticarial papules arranged in a reticular pattern.
Raslan, Wasim +3 more
core +1 more source
, 2018 Background Currently available tools to monitor patients with chronic prurigo over time focus on pruritus and quality of life parameters, while no instrument objectively assessing the pruriginous lesions is yet available.
Pereira, M. P +19 more
core +1 more source
Nemolizumab for Pruritus Control in Cutaneous T‐Cell Lymphoma: A Case Series
JDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Yenny Angela +2 more
wiley +1 more source
The SWITCH algorithm: An expert consensus on treat‐to‐target criteria for chronic prurigo
Journal of the European Academy of Dermatology and Venereology, Volume 40, Issue 7, Page 1185-1194, July 2026.The SWITCH project assessed patients' most distressing symptoms and therapy goals, followed by an expert‐based consensus procedure to define T2T criteria for patients with chronic prurigo (CPG)/prurigo nodularis. Based on these validated criteria, a 4‐step SWITCH algorithm was established to enhance CPG therapy outcomes and reduce patient burden ...
Lea S. Stahl +16 more
wiley +1 more source
Acta Dermato-Venereologica, 2017 Substance P (SP) and its receptor neurokinin 1 (NK1R) are thought to be involved in the pathogenesis of chronic prurigo. Here, we assessed SP serum levels, cutaneous NK1R expression, and the effects of topical aprepitant, an NK1R antagonist, in patients ...
Tatevik Ohanyan +7 more
doaj +1 more source
Nemolizumab in prurigo nodularis up to 100 weeks: OLYMPIA LTE interim analysis
Journal of the European Academy of Dermatology and Venereology, Volume 40, Issue 7, Page 1195-1207, July 2026.In this interim analysis of the OLYMPIA long‐term extension trial, nemolizumab exhibited sustained efficacy and was well tolerated through 100 weeks, with most adverse events being mild/moderate. Patients showed clinically meaningful improvements in core signs and symptoms.
Franz J. Legat +22 more
wiley +1 more source
, 1910 Stereocard for Prurigo. The front of the card depicts an image of the disease and the back of the card lists information about the disease including a description, diagnoses, and ...
core
Prurigo pigmentosa from contact allergy to chrome in detergent
, 2018 Prurigo pigmentosa is a recurrent inflammatory dermatosis characterized by pruritic erythematous papules and reticulate hyperpigmentation that occurs most frequently in spring and summer. The etiology of prurigo pigmentosa remains unknown.
최유원, 명기범, 최혜영
core +1 more source